Successful therapy matters! We can join your pharma project's journey at any stage from the first in-silico seed through in vitro and in vivo pharmacology to clinical proof-of-concept
Enabling technologies for comprehensive cell-based compound characterization to support pharmaceutical product development and bed-to-bench side translation.
Exploring indication spaces for targets and compounds, for new ideas as well as for shelved projects or even for established drugs.
We have diverse and measurable experience across the full range of oncology drug discovery programs.
Our deep therapeutic expertise in oncology covers the full range of relevant pathways, from targeted therapies to novel and emerging therapies.
We provide a state-of-the-art functional genomics platform to characterize both drug targets and the mode-of-action of bioactive molecules for oncology, cardiovascular and gynecological research.
Identification and validation of pharmacodynamic biomarkers. PK/PD studies for identification of the driver of efficacy, supporting clinical dose prediction and proving relevant exposure levels in early clinical studies. Identification of predictive biomarkers for indication profiling and patient selection.